Cargando…
Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study
BACKGROUND: The availability of pharmacogenomic (PGx) methods to determine the right drug and dosage for individualized patient treatment has increased over the past decade. Adoption of the resulting PGx reports in a clinical setting and monitoring of clinical outcomes is a challenging and long-term...
Autores principales: | Tagwerker, Christian, Carias-Marines, Mary Jane, Smith, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414297/ https://www.ncbi.nlm.nih.gov/pubmed/37725552 http://dx.doi.org/10.2196/32902 |
Ejemplares similares
-
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
por: Tagwerker, Christian, et al.
Publicado: (2022) -
Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
por: Hetti Arachchilage, Madara
Publicado: (2022) -
Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
por: Rathi, Komal
Publicado: (2022) -
Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019) -
Pharmacogenomic considerations in the opioid management of pain
por: Jannetto, Paul J, et al.
Publicado: (2010)